Could a hidden nerve condition be more common in lung cancer than we think?

NCT ID NCT07075627

Terminated Knowledge-focused Sponsor: Addario Lung Cancer Medical Institute Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study is looking at how often people with small cell lung cancer also have symptoms of Lambert-Eaton myasthenic syndrome (LEMS), a condition that affects the nerves and can cause muscle weakness. Researchers will review medical records and check for LEMS symptoms in adults diagnosed with small cell lung cancer. The goal is to better understand how common this condition is in this group of patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this study succeeds, it could lead to better awareness and earlier detection of LEMS in people with small cell lung cancer, potentially improving their quality of life.
What could go wrong: This is an observational study, so it won't test any treatment. It may not capture all cases of LEMS, and the findings might not apply to everyone with small cell lung cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAMBERT EATON MYASTHENIC SYNDROME (LEMS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Lambert-Eaton myasthenic syndrome small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LAMBERT EATON MYASTHENIC SYNDROME (LEMS) SMALL CELL LUNG CANCER ( SCLC )

Contacts and locations

Locations

Dana-Farber Cancer Institute

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.